The U.S. Food and Drug Administration just approved a medical device that wouldn’t look out of place in the latest circumstances. StarCraft installment. The FDA on Thursday approved Cresilon Inc’s Traumagel as an emergency treatment to control moderate to severe bleeding. The gel is expected to hit shelves later this year.
The product uses proprietary algae hydrogel technology developed by the Brooklyn-based company. This is the second gel-based treatment Cresilon has successfully launched, following the FDA’s approval of its hemostatic gel in June 2023. Repair bleeding caused by more serious injuries such as gunshot wounds, stab wounds and car accidents.
The FDA approved Traumagel based on preclinical data showing it performed similarly to standard wound care treatments used today. However, the company argues that their product has several advantages over existing interventions, such as taking just seconds to start working. The gel is also said to be easy to use and comes with a prefilled syringe, requiring no additional pressure on the wound and can be used to treat all types of bleeding.
“For traumatic wound patients, the ability to quickly stop bleeding and stop life-threatening bleeding at the point of care can be the difference between life and death,” said Cresilon CEO, co-founder and inventor. Joe Landolina in company statement. “FDA approval of Traumagel is a monumental milestone for Cresilon and brings us another step forward in our mission to save lives and change the standard of care in wound treatment. Our proprietary hemostatic gel technology is a game changer A game changer, unlike any other hemostatic agent currently in use.
The company expects to begin rolling out the gel in late 2024 and sell its products to the U.S. military, government health agencies, emergency medical services systems and other medical professionals who regularly treat trauma patients. The company is also working with the U.S. Department of Defense to research and develop a new product as a potential field and pre-hospital treatment to help manage life-threatening brain hemorrhages and traumatic brain injuries. According to the company, early results are encouraging.
Scientists elsewhere have been working on their own gel technology aimed at improving health care. For example, researchers have developed gel-infused bandages to speed healing, while others have used the gel as a form of male birth control or to help treat conditions like Parkinson’s disease or back pain.
